(Q34409802)

English

Bosentan treatment of digital ulcers related to systemic sclerosis: results from the RAPIDS-2 randomised, double-blind, placebo-controlled trial

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

2 August 2017

Bosentan treatment of digital ulcers related to systemic sclerosis: results from the RAPIDS-2 randomised, double-blind, placebo-controlled trial (English)

1 reference

Europe PubMed Central

2 August 2017

0 references

Marco Matucci-Cerinic

1

object named as

Marco Matucci-Cerinic

0 references

1 reference

ORCID Public Data File 2021

author name string

Christopher P Denton

2

1 reference

Europe PubMed Central

2 August 2017

Daniel E Furst

3

1 reference

Europe PubMed Central

2 August 2017

Maureen D Mayes

4

1 reference

Europe PubMed Central

2 August 2017

Vivien M Hsu

5

1 reference

Europe PubMed Central

2 August 2017

Patrick Carpentier

6

1 reference

Europe PubMed Central

2 August 2017

Fredrick M Wigley

7

1 reference

Europe PubMed Central

2 August 2017

Carol M Black

8

1 reference

Europe PubMed Central

2 August 2017

Barri J Fessler

9

1 reference

Europe PubMed Central

2 August 2017

Peter A Merkel

10

1 reference

Europe PubMed Central

2 August 2017

Janet E Pope

11

1 reference

Europe PubMed Central

2 August 2017

Nadera J Sweiss

12

1 reference

Europe PubMed Central

2 August 2017

Mittie K Doyle

13

1 reference

Europe PubMed Central

2 August 2017

Bernhard Hellmich

14

1 reference

Europe PubMed Central

2 August 2017

Thomas A Medsger

15

1 reference

Europe PubMed Central

2 August 2017

Adele Morganti

16

1 reference

Europe PubMed Central

2 August 2017

Fabrice Kramer

17

1 reference

Europe PubMed Central

2 August 2017

Joseph H Korn

18

1 reference

Europe PubMed Central

2 August 2017

James R Seibold

19

1 reference

Europe PubMed Central

2 August 2017

language of work or name

0 references

publication date

30 August 2010

1 reference

Europe PubMed Central

2 August 2017

Annals of the Rheumatic Diseases

1 reference

Europe PubMed Central

2 August 2017

70

1 reference

Europe PubMed Central

2 August 2017

1

1 reference

Europe PubMed Central

2 August 2017

32-38

1 reference

Europe PubMed Central

2 August 2017

Digital ulcers: overt vascular disease in systemic sclerosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3002766

6 July 2018

Vascular disease in scleroderma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3002766

6 July 2018

Statins: potentially useful in therapy of systemic sclerosis-related Raynaud's phenomenon and digital ulcers

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3002766

6 July 2018

Natural history of ischemic digital ulcers in systemic sclerosis: single-center retrospective longitudinal study.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3002766

6 July 2018

Therapeutic challenges for systemic sclerosis: facts and future targets

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3002766

6 July 2018

Clinical risk assessment of organ manifestations in systemic sclerosis: a report from the EULAR Scleroderma Trials And Research group database

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3002766

6 July 2018

Bosentan treatment for pulmonary arterial hypertension related to connective tissue disease: a subgroup analysis of the pivotal clinical trials and their open-label extensions.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3002766

6 July 2018

Digital ulcers in systemic sclerosis: prevention by treatment with bosentan, an oral endothelin receptor antagonist.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3002766

6 July 2018

A new era in the management of pulmonary arterial hypertension related to scleroderma: endothelin receptor antagonism

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3002766

6 July 2018

Endothelin and endothelin receptor antagonists in systemic rheumatic disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3002766

6 July 2018

Measuring disease activity and functional status in patients with scleroderma and Raynaud's phenomenon.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3002766

6 July 2018

Systemic sclerosis: demographic, clinical, and serologic features and survival in 1,012 Italian patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3002766

6 July 2018

Continuous intravenous epoprostenol for pulmonary hypertension due to the scleroderma spectrum of disease. A randomized, controlled trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3002766

6 July 2018

The value of the Health Assessment Questionnaire and special patient-generated scales to demonstrate change in systemic sclerosis patients over time

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3002766

6 July 2018

Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3002766

6 July 2018

Comparison of intravenous infusions of iloprost and oral nifedipine in treatment of Raynaud's phenomenon in patients with systemic sclerosis: a double blind randomised study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3002766

6 July 2018

Intravenous iloprost treatment of Raynaud's phenomenon and ischemic ulcers secondary to systemic sclerosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3002766

6 July 2018

Bosentan therapy in patients with Eisenmenger syndrome: a multicenter, double-blind, randomized, placebo-controlled study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3002766

27 October 2018

Patient perception of UK scleroderma services--results of an anonymous questionnaire

1 reference

https://pubmed.ncbi.nlm.nih.gov/20805294

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Bosentan therapy for pulmonary arterial hypertension

1 reference

https://pubmed.ncbi.nlm.nih.gov/20805294

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1136/ARD.2010.130658

1 reference

Europe PubMed Central

2 August 2017

1 reference

Europe PubMed Central

2 August 2017

1 reference

Europe PubMed Central

2 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34409802&oldid=1583239450"